Premium Intraocular Lenses in Glaucoma—A Systematic Review
Bioengineering · 22.08.2023 · 10 (9) · 993
DOI: 10.3390/bioengineering10090993 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 22.08.2023. Verfasst von Ashley Shuen Ying Hong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The incidence of both cataract and glaucoma is increasing globally. With increasing patient expectation and improved technology, premium intraocular lenses (IOLs), including presbyopia-correcting and toric IOLs, are being increasingly implanted today. However, concerns remain regarding the use of premium IOLs, particularly presbyopia-correcting IOLs, in eyes with glaucoma. This systematic review evaluates the use of premium IOLs in glaucoma. A comprehensive search of the MEDLINE database was performed from inception until 1 June 2023. Initial search yielded 1404 records, of which 12 were included in the final review of post-operative outcomes. Studies demonstrated high spectacle independence for distance and good patient satisfaction in glaucomatous eyes, with positive outcomes also in post-operative visual acuity, residual astigmatism, and contrast sensitivity. Considerations in patient selection include anatomical and functional factors, such as the type and severity of glaucomatous visual field defects, glaucoma subtype, presence of ocular surface disease, ocular changes after glaucoma surgery, and the reliability of disease monitoring, all of which may be affected by, or influence, the outcomes of premium IOL implantation in glaucoma patients. Regular reviews on this topic are needed in order to keep up with the rapid advancements in IOL technology and glaucoma surgical treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
- Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore 308433, Singapore.
- Department of Ophthalmology, National Healthcare Group Eye Institute, Woodlands Health Campus, Singapore 768024, Singapore.
- Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.
- Department of Ophthalmology, Mayo Clinic, Jacksonville, FL 32224, USA.
ORCID-Profile: Bryan Chin Hou Ang
Zitieren
APA
Hong, A. S. Y., Ang, B. C. H., Dorairaj, E., & Dorairaj, S. (2023). Premium Intraocular Lenses in Glaucoma—A Systematic Review. Bioengineering, 10(9), 993. https://doi.org/10.3390/bioengineering10090993
Vancouver
Hong ASY, Ang BCH, Dorairaj E, Dorairaj S. Premium Intraocular Lenses in Glaucoma—A Systematic Review. Bioengineering. 2023;10(9):993. doi:10.3390/bioengineering10090993
BibTeX
@article{Hong2023,
author = {Hong, Ashley Shuen Ying and Ang, Bryan Chin Hou and Dorairaj, Emily and Dorairaj, Syril},
title = {Premium Intraocular Lenses in Glaucoma—A Systematic Review},
journal = {Bioengineering},
year = {2023},
volume = {10},
number = {9},
pages = {993},
doi = {10.3390/bioengineering10090993}
}
EUVIMED